Albany Medical College
amc.eduTotal trials
78
Active
10
Phase 3
4
Total enrollment
9,854
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Tranexamic Acid | — | — | — | — | — | 2 | |
| Ibuprofen 400 mg, TID | — | — | — | — | — | 1 |
Next readouts
- 2021-01-01
- 2026-03-01
Top conditions
- Patent Ductus Arteriosus4
- Chronic Pain3
- Neuropathic Pain3
- Prostate Cancer3
- Pain, Postoperative2
- Nocturnal Enuresis2
- Failed Back Surgery Syndrome2
- Complex Regional Pain Syndromes2
Frequently asked questions about Albany Medical College
- How many clinical trials does Albany Medical College have on ClinicalTrials.gov?
- Albany Medical College is listed as the lead sponsor on 78 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Albany Medical College's trials are in Phase 3?
- 4 of Albany Medical College's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Albany Medical College focus on?
- Albany Medical College's most-studied conditions on ClinicalTrials.gov are Patent Ductus Arteriosus, Chronic Pain, Neuropathic Pain, Prostate Cancer, Pain, Postoperative.
- When are Albany Medical College's next clinical trial readouts?
- Albany Medical College has 2 upcoming primary-completion readouts tracked here; the soonest is “Tranexamic Acid Infusion During Elective Spine Surgery”, expected around 2021-01-01.